The SpaceX Crew Dragon spacecraft, atop a Falcon 9 booster rocket, is connected to the crew access arm and launch tower on Pad39A at the Kennedy Space Center in Cape Canaveral, Florida, May 29, 2020. Photo: REUTERS/Steve Nesius. CTech – A SpaceX Falcon 9 launcher destined for the International Space Station was launched last week with a smart laboratory developed by Israeli company SpacePharma, carrying, among other experiments, a nanotechnology cancer treatment developed by Ayana Pharma from Jerusalem. Doxil is the first nanotechnology drug to receive FDA approval. The purpose of the experiment is to test for the first time...